TCRS was acquired by Abzena on 11 December 2015. See Press Release.
TCRS is a contract research and manufacturing organization geared towards providing comprehensive chemistry services to pharmaceutical, biotech and agrochemical companies as well as governmental and academic research institutes. The company has a strong background in synthetic organic chemistry and expertise in bioconjugation, including production of antibody-drug conjugates (ADCs).
TCRS embraces the standards of team work, confidentiality, and reliability with innovative solutions to your most challenging research requirements. Customer satisfaction is our highest priority.
TCRS is part of the Abzena group of companies.